110 related articles for article (PubMed ID: 16037415)
21. Biotransformation of trans-1,1,1,3-tetrafluoropropene (HFO-1234ze).
Schuster P; Bertermann R; Rusch GM; Dekant W
Toxicol Appl Pharmacol; 2009 Sep; 239(3):215-23. PubMed ID: 19573548
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of codeine after parenteral and oral dosing in the rat.
Shah J; Mason WD
Drug Metab Dispos; 1990; 18(5):670-3. PubMed ID: 1981718
[TBL] [Abstract][Full Text] [Related]
23. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
Fukano Y; Kawazu K
Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
[TBL] [Abstract][Full Text] [Related]
24. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
25. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia.
Low BS; Ng BH; Choy WP; Yuen KH; Chan KL
Planta Med; 2005 Sep; 71(9):803-7. PubMed ID: 16206032
[TBL] [Abstract][Full Text] [Related]
26. Biotransformation of an alpha4beta2 nicotinic acetylcholine receptor partial agonist in sprague-dawley rats and the dispositional characterization of its N-carbamoyl glucuronide metabolite.
Shaffer CL; Ryder TF; Venkatakrishnan K; Henne IK; O'Connell TN
Drug Metab Dispos; 2009 Jul; 37(7):1480-9. PubMed ID: 19339375
[TBL] [Abstract][Full Text] [Related]
27. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
28. The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans.
Mannens GS; Hendrickx J; Janssen CG; Chien S; Van Hoof B; Verhaeghe T; Kao M; Kelley MF; Goris I; Bockx M; Verreet B; Bialer M; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):554-65. PubMed ID: 16936066
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct-cannulated rats.
Chen Y; Cheng D; Marugan JJ; Manthey C; Tomczuk B; Huebert N
Biopharm Drug Dispos; 2008 May; 29(4):219-30. PubMed ID: 18260095
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone.
Shayeganpour A; Hamdy DA; Brocks DR
Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
[TBL] [Abstract][Full Text] [Related]
32. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
33. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
[TBL] [Abstract][Full Text] [Related]
34. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
35. Comparison of oral bioavailability of genistein and genistin in rats.
Kwon SH; Kang MJ; Huh JS; Ha KW; Lee JR; Lee SK; Lee BS; Han IH; Lee MS; Lee MW; Lee J; Choi YW
Int J Pharm; 2007 Jun; 337(1-2):148-54. PubMed ID: 17280808
[TBL] [Abstract][Full Text] [Related]
36. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses.
Beránková K; Szkutová M; Balíková M
Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens.
De Boever S; Baert K; De Backer P; Croubels S
J Vet Pharmacol Ther; 2005 Dec; 28(6):575-80. PubMed ID: 16343291
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of the new antiepileptic and CNS drug RWJ-333369 following single and multiple dosing to humans.
Yao C; Doose DR; Novak G; Bialer M
Epilepsia; 2006 Nov; 47(11):1822-9. PubMed ID: 17116021
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the pharmacokinetics of dioscin in rat.
Li K; Tang Y; Fawcett JP; Gu J; Zhong D
Steroids; 2005 Jul; 70(8):525-30. PubMed ID: 15894036
[TBL] [Abstract][Full Text] [Related]
40. Effects of ellagic acid by oral administration on distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats.
Ho CC; Lai YS; Wang DY; Chen YS; Lee JH; Tang NI; Chung JG
In Vivo; 2005; 19(1):143-56. PubMed ID: 15796167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
